Steven L Basta Insider Trading $MNLO VYNE Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven L Basta.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven L Basta. Steven L Basta is Director in VIVEVE MEDICAL, INC. ($VIVE) and Chief Executive Officer in BIOFORM MEDICAL INC ($BFRM) and Director in Carbylan Therapeutics, Inc. ($CBYL) and Chief Executive Officer in Menlo Therapeutics Inc. ($MNLO) and Director in Menlo Therapeutics Inc. ($MNLO) and See Remarks in Menlo Therapeutics Inc. ($MNLO).
Steven L Basta in VYNE Therapeutics Inc.
Trading Symbol: MNLOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven L Basta: Director, See Remarks, Chief Executive Officer
Holdings: 536,537 shares
Latest Transaction: Aug 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven L Basta in VYNE Therapeutics Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BFRM, KALV, VIVE, MNLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 05 2020 | MNLO | Menlo Therapeutics ... | Basta Steven L | Director | Option Exercise | A | 1.72 | 22,500 | 38,700 | 22,500 | |
Apr 07 2020 | MNLO | Menlo Therapeutics ... | Basta Steven L | Director | Grant | A | 0.00 | 14,499 | 0 | 536,537 | 522 K to 536.5 K (+2.78 %) |
Mar 23 2020 | MNLO | Menlo Therapeutics ... | Basta Steven L | Director | Option Exercise | A | 2.67 | 45,000 | 120,150 | 45,000 | |
Mar 11 2020 | MNLO | Menlo Therapeutics ... | Basta Steven L | Director | Grant | A | 0.00 | 7,108 | 0 | 522,038 | 514.9 K to 522 K (+1.38 %) |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,000 | 0 | 357,641 | |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,000 | 0 | 357,641 | |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Option Exercise | M | 0.00 | 238,800 | 0 | 0 | |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Option Exercise | M | 0.00 | 238,800 | 0 | 0 | |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Buy | M | 1.83 | 14,000 | 25,620 | 509,764 | 495.8 K to 509.8 K (+2.82 %) |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Buy | M | 1.83 | 14,000 | 25,620 | 509,764 | 495.8 K to 509.8 K (+2.82 %) |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Payment of Exercise | F | 4.52 | 85,210 | 385,149 | 495,764 | 581 K to 495.8 K (-14.67 %) |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Payment of Exercise | F | 4.52 | 85,210 | 385,149 | 495,764 | 581 K to 495.8 K (-14.67 %) |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Buy | M | 0.00 | 238,800 | 0 | 580,974 | 342.2 K to 581 K (+69.79 %) |
Dec 13 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Buy | M | 0.00 | 238,800 | 0 | 580,974 | 342.2 K to 581 K (+69.79 %) |
Jul 31 2019 | MNLO | Menlo Therapeutics ... | Basta Steven L | See Remarks | Option Exercise | A | 0.00 | 238,800 | 0 | 1,050,100 | |
Dec 12 2018 | MNLO | Menlo Therapeutics ... | Basta Steven L | Chief Executive Off ... | Option Exercise | A | 5.51 | 141,900 | 781,869 | 141,900 |
Page: 1